Metagenomics Market Report 2026

The metagenomics market size has grown rapidly in recent years. It will grow from $2.31 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing sequencing adoption, rising microbial diversity studies, growth in environmental microbiology research, expanding pcr machine availability, rising clinical diagnostic usage.

The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $4.58 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to advancement in sequencing technologies, growing demand for microbiome-based therapeutics, increasing r&d in bioinformatics, rising investment in environmental monitoring, expansion of precision medicine applications. Major trends in the forecast period include expansion of precision genomics for microbial community profiling, AI-enhanced metagenomic data interpretation, automation in metagenomic sample processing, cloud-based storage for large-scale sequencing data, iot-integrated environmental microbial monitoring.

The expanding agriculture sector is anticipated to drive the growth of the metagenomics market in the coming years. The agriculture sector encompasses the extensive industry engaged in cultivating crops, raising livestock, and producing food and other essential agricultural products that support global economies and food security. This sector is growing due to increasing global food demand, advancements in sustainable farming practices, and greater adoption of modern technologies that enhance yield and resource efficiency. Metagenomics contributes to agricultural productivity by analyzing microbial communities in soil and crops, enabling precision farming decisions related to soil health, nutrient management, disease control, and environmental sustainability. For example, in December 2023, the U.S. Department of Agriculture Economic Research Service, a U.S.-based government agency, reported that U.S. agricultural exports reached USD 178.7 billion in 2023, indicating continued growth of the agriculture sector and increased adoption of advanced technologies to boost productivity. As a result, the expanding agriculture sector is fueling the growth of the metagenomics market.

Major companies in the metagenomics market are concentrating on creating advanced solutions, such as high-throughput sequencing platforms, to enhance accuracy, efficiency, and reproducibility in the analysis of microbiomes and microbial communities. High-throughput sequencing platforms are sophisticated technologies capable of rapidly reading and analyzing millions of DNA or RNA sequences at once, facilitating large-scale genomic and metagenomic studies. For example, in August 2024, MGI Tech Co. Ltd, a China-based sequencing technology company, introduced its Human Microbiome Metagenomics Sequencing Package, providing high automation across the entire workflow from stool collection to data output, flexible throughput options to accommodate different lab sizes, and validated performance across multiple biological sample types for human microbiome research. This package aims to simplify microbiome studies by integrating optimized sample processing, library preparation, sequencing, and bioinformatics analysis, allowing researchers to achieve accurate, reproducible, and comprehensive insights into microbial communities while reducing hands-on time and operational complexity.

In March 2024, Clinical Microbiomics A/S, a microbiome science company based in Denmark, acquired DNASense ApS for an undisclosed sum. Through this acquisition, Clinical Microbiomics seeks to strengthen its metagenomic and long-read DNA/RNA sequencing capabilities and expand its bioinformatics services for microbiome research and diagnostics. DNASense ApS, also based in Denmark, is a CRO company offering metagenomics services, with a focus on long-read DNA and RNA sequencing technologies for microbiome analysis.

Major companies operating in the metagenomics market are Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation.

North America was the largest region in the global metagenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on molecular biology instruments and sequencing reagents have increased import costs, affecting research laboratories and biotechnology companies dependent on foreign technologies. Regions relying heavily on imported DNA sequencers - particularly Asia-Pacific and Latin America - face slower procurement cycles and higher operational expenses. However, tariffs have encouraged domestic production of reagents, promoted local manufacturing of sequencing equipment, and stimulated innovation in cost-effective metagenomic workflows, slightly reducing long-term dependency on foreign suppliers.

The metagenomics market research report is one of a series of new reports that provides metagenomics market statistics, including metagenomics industry global market size, regional shares, competitors with a metagenomics market share, detailed metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. This metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Metagenomics is a branch of scientific research that focuses on studying genetic material (DNA or RNA) directly obtained from environmental samples or complex microbial communities. It emphasizes analyzing the collective genomic information within a sample rather than isolating and examining individual organisms.

The primary categories of products used in metagenomics include instruments, kits and reagents, and software and services. Instruments are the tools and equipment employed for sample collection, DNA, and RNA extraction. This encompasses various workflows, such as sequencing, pre-sequencing, and data analysis, and serves multiple applications, including environmental studies, clinical diagnostics, drug discovery, biotechnology, food and nutrition, and more. These products are utilized by a wide range of end-users, including pharmaceutical companies, research laboratories, biotechnology firms, pathology laboratories, and academic and research institutions.

The metagenomics market consists of revenues earned by entities by providing metagenomic services such as meta transcriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and meta transcriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.